Monashee Scales Back Structure: GPCR Bet Reassessed
A major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
Learn when to consider realigning your budget by spotting warning signs such as sinking savings or rising debt. Plan a proactive reset to improve cash flow.
19,009 articlesA major hedge fund slashed its stake in Structure Therapeutics, prompting questions about the future path for GPCR-fo...
The stock move is sharp, but so is the story behind choice hotels stock down. An investor dumped more than $100 milli...
A director just bought more than 11,000 Ardent Health shares, sparking questions about the stock after this insider m...
As 2026 unfolds, investors face a choice between two very different travel giants. One leans on software and hosts to...
A sharp 178% EPS rise is grabbing attention, paired with an insider stock sale at Rogers Corp. This article breaks do...
When the Fed signals a policy shift, traders rush to position. This article dives into the appeal of a 3X Financial B...
Looking to find a better space stock: spacemobile? This guide breaks down AST SpaceMobile and Rocket Lab, weighing te...
As Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
Sabre, a travel-technology stalwart, is navigating a recovering travel market and shifting tech spend. This article b...
Imagine a world where your phone pays you back for every scroll and tap. This article dives into Mode Mobile, a specu...
AI stocks are on fire, yet one AI stock has fallen 24.27% from its recent high. This guide explains why the rally has...
C3.AI stock has shed shares in 2026, but that drop raises the question: is this a buying opportunity or a trap? This ...